N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease.
Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Bazzan AJ, Zhong L, Bowens BK, Chervoneva I, Intenzo C, Newberg AB.
Monti DA, et al. Among authors: zabrecky g.
Clin Pharmacol Ther. 2019 Oct;106(4):884-890. doi: 10.1002/cpt.1548. Epub 2019 Jul 17.
Clin Pharmacol Ther. 2019.
PMID: 31206613
Clinical Trial.